Altogether, these results suggest that anti-ZSCAN1 autoantibodies are a feasible diagnostic marker for ROHHAD syndrome not associated with a tumor. The gene discussed is ZSCAN1; the disease is rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.